BackCynata Therapeutics Limited Overview
Cynata Therapeutics Limited

Cynata Therapeutics Limited Return on Equity

Cynata Therapeutics Limited (CYP.AX) has a ROE of 4701.47%, above the Healthcare sector average of 9.17%.

Get informed when a big investor buys or sells

+ Follow

ROE

4701.47%

Return on Equity

4701.47%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Cynata Therapeutics Limited (CYP.AX) FAQ

Cynata Therapeutics Limited's return on equity stands at 4701.47%. That is above the Healthcare sector average of 9.17%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Cynata Therapeutics Limited sits higher the Healthcare benchmark (9.17%) with a ROE of 4701.47%. That is roughly 51149.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 4701.47% for Cynata Therapeutics Limited means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Cynata Therapeutics Limited's ROE evolved across reporting periods, while the comparison chart places CYP.AX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, ROE is commonly used to spot outliers. Cynata Therapeutics Limited's reading of 4701.47% (sector avg 9.17%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.

Questions & Answers